“When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?”

Javier Benítez pointed me to this JAMA article by Paul Young, Christopher Nickson, and Anders Perner, “When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?”, which begins: Understanding whether the results of a randomized clinical trial (RCT) are clinically actionable is challenging. Reporting standards adopted by JAMA and other leading journals lead to …